Reaction Details |
| Report a problem with these data |
Target | Tyrosine-protein kinase BTK [14-552] |
---|
Ligand | BDBM324328 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | In Vitro BTK Kinase Assay |
---|
IC50 | <1.000±n/a nM |
---|
Citation | Hopkins, BT; Ma, B; Prince, R; Marx, I; Lyssikatos, JP; Zheng, F; Peterson, M; Patience, DB Inhibiting agents for bruton's tyrosine kinase US Patent US11858926 Publication Date 1/2/2024 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Tyrosine-protein kinase BTK [14-552] |
---|
Name: | Tyrosine-protein kinase BTK [14-552] |
Synonyms: | Tyrosine-protein kinase BTK (14-552) |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 62318.43 |
Organism: | Homo sapiens (Human) |
Description: | Q06187[14-552] |
Residue: | 539 |
Sequence: | SQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNP
PPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIR
YNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILENRNGSLKPGSSHRKTKKPLPPTPE
EDQILKKPLPPEPAAAPVSTSELKKVVALYDYMPMNANDLQLRKGDEYFILEESNLPWWR
ARDKNGQEGYIPSNYVTEAEDSIEMYEWYSKHMTRSQAEQLLKQEGKEGGFIVRDSSKAG
KYTVSVFAKSTGDPQGVIRHYVVCSTPQSQYYLAEKHLFSTIPELINYHQHNSAGLISRL
KYPVSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK
EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF
QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT
|
|
|
BDBM324328 |
---|
n/a |
---|
Name | BDBM324328 |
Synonyms: | 5-(tert-butyl)-N-(8- (2-((1- ethyl-1H-pyrazol-4- yl)amino)pyrimidin-4- yl)-2-(tetrahydrofuran- 3-yl)- 2,3,4,5-tetrahydro- 1H-benzo[c]azepin- 5-yl)- 1,3,4-oxadiazole-2- carboxamide | US10189829, Compound 96 | US10227341, Compound 96 | US10961237, Compound 96 | US11858926, Compound 96 |
Type | Small organic molecule |
Emp. Form. | C30H37N9O3 |
Mol. Mass. | 571.6733 |
SMILES | CCn1cc(Nc2nccc(n2)-c2ccc3C(CCN(Cc3c2)C2CCOC2)NC(=O)c2nnc(o2)C(C)(C)C)cn1 |
Structure |
|